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Only patients in Ivabradine demonstrated further improvement in LVESVi
(73  15 ml/m2 to 62  15 ml/m2, p = 0.001), LVEDVi (103  19 ml/
m2 to 95  18 ml/m2, p = 0.001), MPI (23% vs 2.7%, p = 0.001), LVEF
(29  3.6 to 34.5  5.4%, p = 0.001) and LVGlobal Strain (13.3  1.6 to
20.2  4.4%, p = 0.001) while those in the control group did not
show any further change. Parameters like E/A, E/A VTI, MPI, E/E'
septal and E/E' lateral showed sustained improvement at 6months only in
the ivabradine group – E/A (1.5  0.5 to 1.1  0.3, p = 0.001), E/A VTI
(1.6  0.5 to 1.1  0.3, p = 0.001), E/e' septal (11.6  3.3 to 9.5  2.2,
p = 0.001), E/e' lateral (11.6  3.2 to 9.8  2.5, p = 0.001).
On multivariate analysis, heart rate reduction was a stronger pre-
dictor of improvement in LVEF ( p = 0.03) than ivabradine treatment
( p = 0.5). Change in HR signiﬁcantly correlated with improvement
in NYHA class (r = +0.4, p = 0.01), fall in BNP levels (r = 0.4,
p = 0.001), better EF (r = 0.38, p = 0.001) and reduction in global
LV strain (r = +0.28, p = 0.03) at 6 months.
Conclusion: Ivabradine added to standard therapy in patients of
DCM with chronic HF produces greater % change in all assessed
parameters including functional class and echocardiographic
parameters especially global LV strain. Ivabradine therapy was
four times more likely to result in HR reduction to <70 bpm at 6
months. Heart rate manipulation with ivabradine may play an
important role in the management of such patients.
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A 24-year-old male patient presented with mild epigastric pain for
2 days and fever for one week. Electrocardiogram of the patient
was suggestive of ventricular tachycardia with a heart rate of 200/
min. Immediately, the patient was injected IV amiodarone 150 mg
as bolus dose. The patient became dyspnoeic and developed frank
pulmonary edema after sometime and had to be managed with
mechanical ventilator support. 2D echocardiography suggestive of
dilated cardiomyopathy which reversed as the patient improved.
The brucella IgM antibodies titres were 3.51 (positive > 1.1). Dilated
cardiomyopathy was caused by Brucella myocarditis which led to
ventricular tachycardia on admission, cardiogenic shock with sub-
sequent development of pulmonary edema and acute renal failure.
The cardiogenic shock led to ischemic hepatitis which was possi-
bly accentuated further by the bolus dose of amiodarone. Thus,
ﬁnal diagnosis of Brucella myocarditis with ischemic hepatitis and
acute kidney injury was made.
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Background: The goal of this study was to evaluate if red cell
distribution width (RDW) can serve as a relatively inexpensive
diagnostic marker in cases of heart failure (HF) in India, where
diagnostic markers such as N Terminal-Pro Brain Natriuretic Pep-
tide (NTP BNP) are expensive.
Methods: This was an cross-sectional observational study con-
ducted from June 2012 to June 2014 in a tertiary care hospital, in
which participants aged ≥18 years, after informed consent was
divided into two groups: Cases – 100 patients with HF diagnosed on
the basis of clinical examination, X-ray chest and Echodoppler and
Controls – 100 patients without HF. Those with conditions which
elevate RDW like anemia, arthritis, neoplasia, hypothyroidism,
liver disease, and inﬂammatory bowel disease were excluded.
SYSMEX KX 21 Automated Hematology Analyserwas used to generate
the complete blood count (CBC) report from which RDW was
compared between the two groups to evaluate its utility as an
independent marker for HF.
Results: Out of the 100 patients of HF, 47 had HF with reduced
ejection fraction (HFREF) and 53 had HF with preserved ejection
fraction (HFPEF). Themean RDWwas signiﬁcantly higher in the HF
patients (53.85  5.39 ﬂ) than controls (42.21  1.66 ﬂ). It was also
found to be signiﬁcantly higher in both subgroups – HFREF (56.96
 5.18 ﬂ) and HFPEF (51.10  3.88 ﬂ) than that in controls. Using the
Spearman's Rho calculator, the value of ‘‘r’’ between RDW and
LVEF is 0.55996 and the two-tailed value of p is 0 which was
statistically signiﬁcant.
Conclusion: RDW is a readily available and relatively inexpensive
test which can be carried out in the HF-population. BothHFREF and
HFPEF patients were found to have signiﬁcantly higher RDW than
controls. Understanding how and why this marker is associated
with HF may provide novel insights into HF pathophysiology.
Further investigation is necessary to determine the pathological
mechanism of the relationship and its prognostic signiﬁcance.
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Introduction: Severe pulmonary artery hypertension (PAH) in
infants is rare presentation without congenital heart disease
(CHD). Cardiac beriberi is often a missed diagnosis and is still
common. Thiamine supplements in unexplained congestive heart
failure (CHF) with severe PAH in a patient from poor socio eco-
nomic (SE) status may be life saving.
Materials and methods: A total of 25 infants (male 18, female 7)
were found to have unexplained severe PAH during period of June
2012 to June 2015were included. All infantswere exclusively breast
fed belonging to low SE strata with their mothers from predomi-
nant rice eating population. Infants with CHD were excluded.
Presentation was poor feeding, excessive cry and/or respiratory
distress. 2D Echo done showed severe PAH and RV dysfunction in
all; 2 patients had associated pericardial and pleural effusion.
Diagnosis of cardiac beriberi was made and thiamine supplement
were started immediately. No other PAH medications were given.
Results:The average age of presentationwas 3.5months (range 1–6
months); weight 4.3 kg (2.8–6.5 kg). Arterial blood gas (ABG) analysis
showed high lactate levels (mean 6.4, range 3.4–17 mmol/l) at pre-
sentation. Mean PA pressures were 74 mmHg (range 50–110mmHg)
at admission. The lactate levels were higher in infants less than
three-month age (n = 10) when compared with older infants (n = 15)
between 3-month and 6-month age group (lactate 9.6 mmol/l vs
4.2 mmol/l respectively, p < 0.05). The infants presenting before
threemonths had severe CHF and two infants presentedwith acute
gasping state with severe lactic acidosis requiring mechanical ven-
tilation. The response of thiamine supplement was rapid, ABG
i n d i a n h e a r t j o u rn a l 7 9 ( 2 0 1 5 ) s 9 9 – s 1 0 7S102
showed normal lactate (mean 0.89, p < 0.02); mean PA pressures
reduced to 20 mmHg (p < 0.05) within 36 h. There was complete
recovery in all. No recurrences observed in average 7months (range
4–24 months) follow-up.
Conclusion: Early clinical suspicion of cardiac beriberi is extremely
important in infants with low SE strata presenting with unex-
plained CHF and severe PAH.
Bicuspid aortic valve with restrictive
cardiomyopathy – A rare case report
N. Praveen
Post Graduate, 3-4-526/36/303 Thrayarsheya Apartments, Opposite
Barkatpura Post Office, Barkatpura, Hyderabad 500027, India
Introduction: Congenital bicuspid aortic valve is themost common
congenital anomaly incardiovascular systemaccounting for1–2%of
the population, more common inmen. Restrictive cardiomyopathy
is a heterogenous group of diseases characterized by a nondilated
left ventricle, often with a well preserved ejection fraction.
Case: A 52-year-old male, nonhypertensive, diabetic came with
complaints of shortness of breath, abdominal distention, pedal
edema. On examination, he had raised JVP, pulse 54/min, BP – 100/
70 mmHg. On CVS examination, there was S1, S2, lungs b/l creps
were heard. His Hb – 10.5 g/dl,WBC counts were normal. Renal
parameters were within normal limits. Liver function tests – nor-
mal. Viral screening – negative. USG abdomen – gross ascites, b/l
pleural effusion, liver size normal. Chest X-ray – cardiomegaly, b/l
pleural effusion. ECG – idioventricular rhythm, low voltage com-
plexes. Echo showed biatrial enlargement with normal sized ven-
tricles and normal systolic function with grade III diastolic
dysfunction. There was bicuspid aortic valve with calciﬁcation,
antero-posteriororientationofcommissuresandpositiveeccentricity
index. There wasmoderate aortic stenosis andmild aortic regurgita-
tion. Due to disparity between the echo ﬁndings and the clinical
situation, restrictivecardiomyopathywassuspectedandaabdominal
fat pad biopsy was done with Congo red staining and subjected to
polar microscopy. The biopsy was positive for amyloidosis.
Discussion: Amyloid deposition in heart is a common occurrence
in systemic amyloidosis (50% occurrence). Fine needle aspiration
of abdominal fat pad is minimally invasive, convenient, safe, eco-
nomical, simple procedure for the tissue diagnosis of AL. It has
sensitivity of 52–88% and speciﬁcity >95%, equal to or better than
rectal biopsies with Congo red staining. Congestive heart failure is
the presenting feature in restrictive cardiomyopathywith amedian
survival is <6 months after onset of heart failure. Gofﬁn et al.
reported the termdystrophic valvular amyloidosis' in a patientwith
a calciﬁc bicuspid aortic valve subjected to aortic valve replacement
on biopsy. Association of a biscupid aortic valve with RCMP is rare
and to the best of our knowledge it is the second case report.
Clinical implications: Association of bicuspid aortic valve with
restrictive cardiomyopathy is rare.
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Background: Heart failure as a chronic progressive disorder of all
heart failure patients eventually progress to a refractory stage
characterized by worsening renal function and resistance to diure-
tic therapy with attending severe edema. A logical treatment for
this ‘‘cardiorenal syndrome’’ is the use of dialysis, which is
efﬁcient in treating both the hypervolemia and azotemia of
refractory heart failure. Peritoneal ultraﬁltration is associated
with preservation of residual renal function, gentle continuous
ultraﬁltration, hemodynamic stability, sodium sieving with
maintenance of normonatremia and perhaps less inﬂammation
than hemodialysis.
Methods: The study was conducted prospectively on cohort of
patients for two years patients with NYHA functional class III/
IV; refractory heart failure with ejection fraction (EF) <45%. And
one out of two criteria (i) persistent dyselectrolytemia (hypona-
tremia or hypokalemia); (ii) at least one previous hospitaliza-
tions for acute heart failure in previous 3 month, were followed
for a median of 3 months after the catheter implantation. To
measure the success of ultraﬁltration, the endpoint will be
deﬁned by changes that occurred in study variables pre- and
post-ultraﬁltration at 3 months. NYHA class, 6 MIN WALK TEST,
days of rehospitalisation or unscheduled visit or admission,
hemoglobin, serum creatinine, eGFR, sodium, NTproBNP. Echo-
cardiographic parameters before and after ultraﬁltration at 3
months.
A total of 19 study subjects were studied, most of them 17 (89.4%)
were male while only 02 (10.6%) were female. We found sig-
niﬁcant increase in ejection fraction measured by Simpson
method. EF before the treatment was (35.4  6.6), (43.1  13.8)
with mean difference (7.64  10.4) at the end of 3 months. After
ultraﬁltration, duration of hospital stay, hospitalization rate and
cases in NYHA class III and IV highly signiﬁcantly reduced
( p < 0.0001), while other parameters like Hb (g%) and EF showed
signiﬁcant increase ( p < 0.0001) after ultraﬁltration. After ultra-
ﬁltration, RVSP signiﬁcantly reduced ( p < 0.001), was marker for
ﬂuid overload state; physical activity index (6MWT) and NYHA
class improved signiﬁcantly in our study over the period of
3 months p < 0.001 and p < 0.01 respectively. Signiﬁcant
reduction was observed in level of NTproBNP. There was
improvement in serum sodium level ( p < 0.05) after ultraﬁltra-
tion. We noticed there was signiﬁcant increase in the hemoglo-
bin (g%).
Conclusion: This preliminary study indicates that ultraﬁltration is
a feasible alternative for the treatment of symptomatic patients
with advanced CHF, persistent ﬂuid overload despite loop diuretic
therapy excluding patient with ESRD and echocardiography is a
good tool to assess effect of ultraﬁltration.
To detect occult coronary artery disease
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hypokinesia
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Aim: Global hypokinesia of left ventricle (GHLV) is uncommon in
ICMP that delays the proper treatment because of confusion
with DCMP as the closest differential diagnosis. Here author
has tried to evaluate the role of coronary angiogram in unex-
plained dilated and signiﬁcant GHLV of with no prior documen-
tation of CAD.
Methods: This was the prospective observational study carried at a
single centre serving the large number of population in North-East
India, which included 30 patients during the period March-2015 to
August-2015 (period of four months). The study group consists of
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